Patent · US Active

CRISPR oligonucleotides and gene editing

US9879283B2 · kind B2 · utility

48Cited by

4References

9Claims

0Family size

Assignees

Life Technologies Corporation · US
THERMO FISHER SCIENTIFIC GENEART GMBH · DE

Inventors

Namritha RAVINDER · Hamilton, CA
Korbinian Heil · Munich, DE
Yizhu GUO · Castro Valley, US
Xiquan LIANG · Escondido, US
Robert Potter · Frederick, US
Sanjay Kumar · Ipswich, US

Key dates

Filing date	Oct 9, 2015
Grant date	Jan 30, 2018
Priority date	—
Expiry date	Oct 9, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2330/30
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present disclosure generally relates to compositions and methods for the genetic modification of cells. In particular, the disclosure relates to CRISPR reagents and the use of such reagents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.